2008
DOI: 10.1038/nature07106
|View full text |Cite
|
Sign up to set email alerts
|

Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA

Abstract: Innate immune defenses are essential for the control of virus infection and are triggered through host recognition of viral macromolecular motifs known as pathogen-associated molecular patterns (PAMPs) 1. Hepatitis C virus (HCV) is an RNA virus that replicates in the liver, and infects 200 million people 2. Infection is governed by hepatic immune defenses triggered by the cellular RIG-I helicase. RIG-I binds PAMP RNA and signals IRF-3 activation to induce the expression of α/β interferon (IFN) and antiviral/in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

16
735
3
4

Year Published

2009
2009
2018
2018

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 670 publications
(772 citation statements)
references
References 30 publications
16
735
3
4
Order By: Relevance
“…MDCs of CP-D viremics were also unable to induce cytokines in response to transfected full-length HCV genomic RNA (Fig. 1C), which contains pathogen-associated molecular patterns sensed by RIG-I (22), in contrast to CP-N patients who had intact responses to all agonists tested, similarly to aviremics. No known clinical characteristics, including infecting genotype, history of antiviral therapy, PVL, and serum aspartate transaminase and alanine transaminase levels, correlated with or predicted those subjects with preserved TRIF-and IFN-b promoter stimulator-1 (IPS-1)-dependent PRR potentials (CP-N subgroup; Table I).…”
Section: Resultsmentioning
confidence: 99%
“…MDCs of CP-D viremics were also unable to induce cytokines in response to transfected full-length HCV genomic RNA (Fig. 1C), which contains pathogen-associated molecular patterns sensed by RIG-I (22), in contrast to CP-N patients who had intact responses to all agonists tested, similarly to aviremics. No known clinical characteristics, including infecting genotype, history of antiviral therapy, PVL, and serum aspartate transaminase and alanine transaminase levels, correlated with or predicted those subjects with preserved TRIF-and IFN-b promoter stimulator-1 (IPS-1)-dependent PRR potentials (CP-N subgroup; Table I).…”
Section: Resultsmentioning
confidence: 99%
“…In the current study, we confirm that HCVc showed a significant, positive correlation with HCV RNA and the frequency of expression by blocking RIG-I and TLR3 signaling. 16,17 In addition, HCV proteins have been shown to upregulate TLR2 and TLR4 expression on Raji cells and peripheral blood mononuclear cells, thereby modulating the cell's pro-inflammatory response. 18,19 Moreover, several studies by our group and others have provided evidence that the HCV core can activate TLR2 on human monocytes, macrophages and Kupffer cells, which induces production of inflammatory cytokines by activating the MyD88-dependent TLR signaling pathway.…”
Section: Resultsmentioning
confidence: 99%
“…RIG-I and MDA5 are activated upon the detection of viral RNA molecules. The mechanisms of this activation have been largely characterized and depend on specific RNA features (19,25,31,45,53,54). RIG-I preferentially recognizes RNA sequences containing 5= triphosphorylated (5=ppp) ends, which represents a nonself RNA PAMP (19).…”
Section: Discussionmentioning
confidence: 99%